Hao Xiaoxiao, Chen Yuechuan, Sahu Divya, Przanowska Róża K, Aaiyas Mujawar, Weidmann Chase A, Nardi Isaac, Weeks Kevin M, Dutta Anindya
University of Alabama at Birmingham, Department of Genetics, Birmingham, Alabama, USA.
University of Virginia, Department of Biochemistry and Molecular Genetics, Charlottesville, Virginia, USA.
J Biol Chem. 2025 May 2;301(6):110172. doi: 10.1016/j.jbc.2025.110172.
A tumor-suppressive long-noncoding RNA (lncRNA) DRAIC (downregulated RNAin cancers) inhibits NF-κB activity and physically interacts with IKKα, a kinase component of the IKK complex, in several cancer types. Here we explore the precise molecular mechanism involved in this interaction and suppression. Using SHAPE-MaP, we identified a 36-nucleotide hairpin (A + B) within DRAIC that is necessary and sufficient for its anti-oncogenic function. RNA immunoprecipitation (RIP) and Electrophoretic mobility shift assays (EMSA) confirmed that this hairpin physically interacts with the coiled coil domain of IKKα. A + B RNA has a high-binding affinity (KD ∼1-7 nM) to IKKα. The binding of A + B disrupts the dimerization of NEMO and IKKα coiled-coil domains, a critical step for IKK action. Consistent with this, A + B inhibits the phosphorylation of the NF-κB inhibitor IκBα and suppresses NF-κB activity. Publicly available tumor RNAseq data revealed that alternative splicing modulates the presence of this critical hairpin: The inclusion of exon 4a (encoding one side of the A + B hairpin) in lung tumors correlates with reduced NF-κB activity. By demonstrating that the A + B hairpin is both necessary and sufficient to inhibit IKK and oncogenic phenotypes, this study underscores the centrality of IKKα interaction and NF-κB inhibition in DRAIC-mediated cancer suppression and indicates that the activity of this lncRNA is regulated by alternative splicing. This study also reveals the first example of a short RNA disrupting coiled-coil dimerization, offering a new approach to disrupt such dimerization in cancer biology.
一种具有肿瘤抑制作用的长链非编码RNA(lncRNA)DRAIC(癌症中下调的RNA)在多种癌症类型中可抑制核因子κB(NF-κB)活性,并与IKK复合物的激酶成分IKKα发生物理相互作用。在此,我们探究了这种相互作用和抑制作用所涉及的精确分子机制。利用SHAPE-MaP,我们在DRAIC中鉴定出一个36个核苷酸的发夹结构(A + B),它对其抗癌功能是必需且充分的。RNA免疫沉淀(RIP)和电泳迁移率变动分析(EMSA)证实,该发夹与IKKα的卷曲螺旋结构域发生物理相互作用。A + B RNA对IKKα具有高结合亲和力(解离常数KD约为1 - 7 nM)。A + B的结合破坏了NEMO和IKKα卷曲螺旋结构域的二聚化,这是IKK发挥作用的关键步骤。与此一致的是,A + B抑制NF-κB抑制剂IκBα的磷酸化并抑制NF-κB活性。公开的肿瘤RNA测序数据显示,可变剪接调节了这个关键发夹的存在:肺肿瘤中外显子4a(编码A + B发夹的一侧)的包含与NF-κB活性降低相关。通过证明A + B发夹对于抑制IKK和致癌表型既是必需的也是充分的,本研究强调了IKKα相互作用和NF-κB抑制在DRAIC介导的癌症抑制中的核心地位,并表明这种lncRNA的活性受可变剪接调控。本研究还揭示了短RNA破坏卷曲螺旋二聚化的首个实例,为在癌症生物学中破坏这种二聚化提供了一种新方法。